Rajavelu Esther
See Remarks
Rajavelu Esther has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: May 7, 2026.
On the most recent filing, Rajavelu Esther is listed as See Remarks at Spero Therapeutics, Inc. Inside the rolling window, Rajavelu Esther reported no open-market purchases and 4 open-market sales totaling $407K in SPRO. The largest disclosed transaction in the window is a sale of 87,917 SPRO shares on Feb 6, 2026, worth $207K.
Companies traded
Other insiders at SPRO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$407K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Rajavelu Esther made?
Rajavelu Esther has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Rajavelu Esther trade?
Rajavelu Esther has filed SEC Form 4 disclosures for 1 company, including SPRO.
When was Rajavelu Esther's most recent SEC Form 4 filing?
Rajavelu Esther's most recent SEC Form 4 filing on Tracefour is dated May 7, 2026.
What is Rajavelu Esther's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Rajavelu Esther is listed as See Remarks.
What is Rajavelu Esther's total buy and sell value in the current window?
Inside the rolling retention window, Rajavelu Esther bought $0 and sold $407K based on SEC Form 4 filings.
What was Rajavelu Esther's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 87,917 SPRO shares on 2026-02-06, worth $207K, per SEC Form 4 filings.